Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2013

Dec 4, 2013

34395_dirs_2013-12-04_7e74c2eb-fe89-404f-a437-bcab2923d912.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2013-11-25

Reporting Person: Innes Guy Archibald (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-25 COMMON STOCK P 132246 $271102.7 Acquired 1064341 Direct
2013-12-02 COMMON STOCK P 4878 $9999.9 Acquired 1069219 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-11-25 WARRANT $2.4 P 132246 Acquired 2018-11-25 COMMON STOCK (132246) Direct

Footnotes

F1: A total of 132,246 Units (1 Unit = 1 common share + 1 warrant to purchase 1 common share) were acquired on November 25, 2013, of which 121,952 Units were purchased at a cost basis of $2.05 per Unit and 10,294 Units were acquired pursuant to the settlement of an existing debt between the Company and Guy Archibald Innes valued at $21,102.70.

F2: The 4,878 shares were purchased at a cost basis of $2.05 per share.